C4X Discovery – City round-up

    News Read

C4X Discovery Holdings, the Manchester-based drugs discovery company, saw annual revenues soar in the six months to January 31, 2023, while pre-tax losses narrowed slightly.

Dr Julie Simmonds and Dr Mike Mitchell, analysts with investment bank Panmure Gordon, said: “Interim results to January put C4XD on track to meet our expectations for the FY. With cash until late FY2024, and further milestones from partners expected, C4XD is evolving its strategy and beginning to focus specifically on treatments for immuno-inflammatory diseases.’

Read the full article here: https://www.thebusinessdesk.com/northwest/news/2113759-city-round-up-c4x-discovery-holdings-nichols-james-fisher

Author: Neil Hodgson, Business Reporter, The Business Desk.com

Dr Julie Simmonds

Managing Director, Research Analyst, Healthcare

Dr Mike Mitchell

Director, Research Analyst, Healthcare

Other insights like this

View all